Abstract 15621: Safety, Efficacy, and Renal Effects of Baxdrostat in Controlled versus Resistant Hypertension: A Systematic Review and Meta-Analysis
Background: Hypertension, particularly resistant hypertension, persists as a major global burden associated with significant challenges in therapeutic management. Baxdrostat, a selective aldosterone synthase inhibitor, can be investigated as a potential therapy for blood pressure treatment. We conducted a meta-analy...